Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
2.
Nutrients ; 13(4)2021 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-33921150

RESUMEN

Low vitamin D is usual; however, data are limited for elite team players. The aim was to investigate the vitamin D levels in Football Club Barcelona (FCB) first division players of six sport modalities. Ninety-five elite male players (27.3 ± 4.6 y) belonging to FCB provided data for vitamin D throughout a season. In this study, 25(OH)D was measured in serum by chemiluminescent immunoassay. Outdoor/indoor training and supplementation were also considered. Total mean 25(OH)D concentrations were 91.9 ± 23.1 nmol/L in all players, with higher mean levels among supplemented players (94.7 ± 24.3 nmol/L). Around 25% of the team players were below optimal levels (<75 nmol/L), but none were below 50 nmol/L. Caucasian, supplemented football and handball players had the highest mean vitamin D concentrations over the whole year, whereas basketball players (indoor training) had the lowest ones. The highest rate of vitamin D insufficiency was found in spring (40%). A positive significant effect was observed for the interaction between indoor/outdoor training and supplementation with 25(OH)D concentrations (p < 0.05). Those team players training outdoors with supplementation had higher total vitamin D concentrations than those with indoors training and/or supplementation. A positive interaction of outdoor training with supplementation exists to determine 25(OH)D concentrations in team players.


Asunto(s)
Atletas/estadística & datos numéricos , Estado Nutricional , Deportes de Equipo , Deficiencia de Vitamina D/epidemiología , Vitamina D/análogos & derivados , Adulto , Suplementos Dietéticos/estadística & datos numéricos , Ayuno/sangre , Humanos , Estudios Longitudinales , Masculino , Prevalencia , Estaciones del Año , España/epidemiología , Vitamina D/análisis , Vitamina D/sangre
3.
Br J Sports Med ; 55(8): 416, 2021 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-33097528

RESUMEN

Football is a global game which is constantly evolving, showing substantial increases in physical and technical demands. Nutrition plays a valuable integrated role in optimising performance of elite players during training and match-play, and maintaining their overall health throughout the season. An evidence-based approach to nutrition emphasising, a 'food first' philosophy (ie, food over supplements), is fundamental to ensure effective player support. This requires relevant scientific evidence to be applied according to the constraints of what is practical and feasible in the football setting. The science underpinning sports nutrition is evolving fast, and practitioners must be alert to new developments. In response to these developments, the Union of European Football Associations (UEFA) has gathered experts in applied sports nutrition research as well as practitioners working with elite football clubs and national associations/federations to issue an expert statement on a range of topics relevant to elite football nutrition: (1) match day nutrition, (2) training day nutrition, (3) body composition, (4) stressful environments and travel, (5) cultural diversity and dietary considerations, (6) dietary supplements, (7) rehabilitation, (8) referees and (9) junior high-level players. The expert group provide a narrative synthesis of the scientific background relating to these topics based on their knowledge and experience of the scientific research literature, as well as practical experience of applying knowledge within an elite sports setting. Our intention is to provide readers with content to help drive their own practical recommendations. In addition, to provide guidance to applied researchers where to focus future efforts.


Asunto(s)
Rendimiento Atlético/fisiología , Dieta Saludable , Política Nutricional , Fútbol/fisiología , Traumatismos en Atletas/rehabilitación , Composición Corporal , Conducta Competitiva/fisiología , Diversidad Cultural , Suplementos Dietéticos , Ambiente , Femenino , Humanos , Masculino , Necesidades Nutricionales , Acondicionamiento Físico Humano/fisiología , Viaje
4.
J Agric Food Chem ; 67(42): 11616-11626, 2019 Oct 23.
Artículo en Inglés | MEDLINE | ID: mdl-31542929

RESUMEN

Avocado peel, a byproduct from the avocado pulp industry, is a promising source of polyphenolic compounds. We evaluated the effect of a proanthocyanidin-rich avocado peel polyphenol extract (AvPPE) on the composition and metabolic activity of human fecal microbiota cultured for 24 h in a bioreactor in the presence of high protein (HP) amounts and the effect of the resulting culture supernatants (CSs) on HT-29Glc-/+ and Caco-2 cells. AvPPE decreased the HP-induced production of ammonia, H2S, propionate, and isovalerate and increased that of indole and butyrate. Microbiota composition was marginally affected by HP, whileAvPPE increased the microorganisms/abundance of phylum Actinobacteria, families Coriobacteriaceae and Ruminococcaceae, and genus Faecalibacterium. AvPPE failed to prevent the HP-induced decrease of HT-29Glc-/+ cell viability and energy efficiency but prevented the HP-induced alterations of barrier function in Caco-2 cells. Additionally, the genotoxic effect of the CSs upon HT-29Glc-/+ was attenuated by AvPPE. Therefore, AvPPE may be considered as a promising product for improving colonic homeostasis.


Asunto(s)
Colon/efectos de los fármacos , Homeostasis/efectos de los fármacos , Persea/química , Extractos Vegetales/farmacología , Polifenoles/farmacología , Proantocianidinas/farmacología , Amoníaco/metabolismo , Bacterias/clasificación , Bacterias/genética , Bacterias/aislamiento & purificación , Bacterias/metabolismo , Butiratos/metabolismo , Células CACO-2 , Colon/microbiología , Dieta Rica en Proteínas , Heces/microbiología , Frutas/química , Microbioma Gastrointestinal/efectos de los fármacos , Humanos , Proantocianidinas/análisis
5.
Food Funct ; 10(7): 4022-4035, 2019 Jul 17.
Artículo en Inglés | MEDLINE | ID: mdl-31218325

RESUMEN

The consumption of high-protein diets (HPDs) increases the flux of undigested proteins moving to the colon. These proteins are hydrolyzed by bacterial proteases and peptidases, releasing amino acids, which in turn are metabolized by the intestinal microbiota (IM) for protein synthesis and production of various metabolites that can exert positive or deleterious effects, depending on their concentrations, at the colonic or systemic level. On the other hand, proanthocyanidins are polymers of flavan-3-ols which cannot be absorbed at the intestinal level, accumulating in the colon where they are fermented by the IM producing metabolites that appear beneficial for colonocytes and also at the peripheral level. This study evaluated the effect of an avocado peel polyphenol extract (AvPPE) rich in proanthocyanidins on the production of cecal bacterial metabolites and microbiota composition in rats fed a HPD. Compared with the normal-protein (NP) group, HPD did not markedly affect the body weight gain of the animals, but increased the kidney weight. Additionally, the HPD induced a higher cecal concentration of ammonia (NH4+/NH3), hydrogen sulfide (H2S) and branched-chain fatty acids (BCFAs). The supplementation with AvPPE attenuated the production of H2S and increased the production of indole. On the other hand, the HPD affected the composition of the cecal microbiota, increasing the relative abundance of the genera Bacteroides and Lactobacillus, while decreasing Prevotella. The AvPPE counteracted the increase induced by the HPD on the genus Lactobacillus, and increased the relative abundance of [Prevotella]. Our results contribute towards explaining the health-promoting effects of proanthocyanidin-rich dietary foodstuffs including fruits and vegetables.


Asunto(s)
Aminoácidos/biosíntesis , Bacterias/efectos de los fármacos , Bacterias/metabolismo , Dieta Rica en Proteínas , Microbioma Gastrointestinal/efectos de los fármacos , Persea/química , Extractos Vegetales/farmacología , Proantocianidinas/farmacología , Amoníaco , Animales , Peso Corporal , Ciego/metabolismo , Ciego/microbiología , Colon/microbiología , Ácidos Grasos Volátiles , Fermentación , Flavonoides/química , Frutas/química , Lactobacillus , Masculino , Modelos Animales , Tamaño de los Órganos , Polifenoles , Ratas , Ratas Wistar
7.
Cancer Prev Res (Phila) ; 2(2): 175-84, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19174580

RESUMEN

Genetically engineered mouse cancer models are among the most useful tools for testing the in vivo effectiveness of the various chemopreventive approaches. The p53-null mouse model of mammary carcinogenesis was previously characterized by us at the cellular, molecular, and pathologic levels. In a companion article, Medina et al. analyzed the efficacy of bexarotene, gefitinib, and celecoxib as chemopreventive agents in the same model. Here we report the global gene expression effects on mammary epithelium of such compounds, analyzing the data in light of their effectiveness as chemopreventive agents. SAGE was used to profile the transcriptome of p53-null mammary epithelium obtained from mice treated with each compound versus controls. This information was also compared with SAGE data from p53-null mouse mammary tumors. Gene expression changes induced by the chemopreventive treatments revealed a common core of 87 affected genes across treatments (P < 0.05). The effective compounds, bexarotene and gefitinib, may exert their chemopreventive activity, at least in part, by affecting a set of 34 genes related to specific cellular pathways. The gene expression signature revealed various genes previously described to be associated with breast cancer, such as the activator protein-1 complex member Fos-like antigen 2 (Fosl2), early growth response 1 (Egr1), gelsolin (Gsn), and tumor protein translationally controlled 1 (Tpt1), among others. The concerted modulation of many of these transcripts before malignant transformation seems to be conducive to predominantly decrease cell proliferation. This study has revealed candidate key pathways that can be experimentally tested in the same model system and may constitute novel targets for future translational research.


Asunto(s)
Biomarcadores de Tumor/genética , Modelos Animales de Enfermedad , Neoplasias Mamarias Experimentales/genética , Lesiones Precancerosas/genética , Pirazoles/uso terapéutico , Quinazolinas/uso terapéutico , Sulfonamidas/uso terapéutico , Tetrahidronaftalenos/uso terapéutico , Proteína p53 Supresora de Tumor/fisiología , Animales , Anticarcinógenos/uso terapéutico , Bexaroteno , Biomarcadores de Tumor/metabolismo , Celecoxib , Inhibidores de la Ciclooxigenasa/uso terapéutico , Receptores ErbB/antagonistas & inhibidores , Femenino , Gefitinib , Perfilación de la Expresión Génica , Glándulas Mamarias Animales/efectos de los fármacos , Glándulas Mamarias Animales/metabolismo , Neoplasias Mamarias Experimentales/tratamiento farmacológico , Neoplasias Mamarias Experimentales/patología , Ratones , Ratones Endogámicos BALB C , Ratones Noqueados , Análisis de Secuencia por Matrices de Oligonucleótidos , Lesiones Precancerosas/tratamiento farmacológico , Lesiones Precancerosas/patología , Proteína Tumoral Controlada Traslacionalmente 1
8.
Exp Hematol ; 33(11): 1337-47, 2005 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16263418

RESUMEN

Mantle cell lymphoma (MCL) is a distinct form of non-Hodgkin's lymphoma (NHL) derived from CD5+ B cells. MCL cells overexpress cyclin D1 as a consequence of translocation of the gene into the immunoglobulin heavy-chain gene locus. MCL is an aggressive form of NHL with frequent relapses after standard-dose chemotherapy. In this context, a variety of novel therapies for patients with MCL have been investigated. In this study, we use an expanded panel of attenuated adenoviruses to study adenovirus-mediated cytotoxicity of MCL cells. Our results demonstrate: 1) adenovirus infection of MCL cells despite the absence of receptor/coreceptor molecules known to be important for adenovirus infection of other cells types; 2) cytotoxicity of MCL cells after infection with specific adenovirus mutants; 3) a high degree of cytotoxicity after infection of some patient samples with viruses lacking the E1B 19k "antiapoptotic" gene; and 4) cytotoxicity after infection with viruses containing mutations in E1A pRb or p300 binding. The extent of cytotoxicity with the panel of viruses demonstrated interpatient variability, but 100% cytotoxicity, as determined by molecular analysis, was detected in some samples. These studies provide the foundation for: 1) the development of adenoviruses as cytotoxic agents for MCL and 2) analyses of key regulatory pathways operative in MCL cells.


Asunto(s)
Infecciones por Adenoviridae , Adenoviridae/patogenicidad , Terapia Biológica/métodos , Linfoma de Células del Manto/terapia , Adenoviridae/genética , Proteínas E1A de Adenovirus/genética , Proteínas E1B de Adenovirus/deficiencia , Proteínas E1B de Adenovirus/genética , Muerte Celular , Humanos , Linfoma de Células del Manto/patología , Mutación , Vacunas Atenuadas/farmacología , Virulencia/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA